Success Metrics

Clinical Success Rate

100.0%

Based on 8 completed trials

Completion Rate

100%(8/8)

Active Trials

0(0%)

Results Posted

100%(8 trials)

Phase Distribution

Ph phase_1

11%

Ph phase_2

11%

Ph phase_3

78%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Phase 1Safety & dosage

1(11.1%)

Phase 2Efficacy & side effects

1(11.1%)

Phase 3Large-scale testing

7(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(8)

Terminated(1)

Detailed Status

Completed8

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (11.1%)

Phase 21 (11.1%)

Phase 37 (77.8%)

Trials by Status

withdrawn111%

completed889%

Recent Activity

0 active trials

Showing 5 of 9

completedphase_2

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

NCT04398706

completedphase_3

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

NCT03691610

completedphase_3

Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)

NCT00496054

completedphase_1

A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)

NCT00953056

withdrawnphase_3

A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

NCT01003431

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT04398706Phase 2

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Completed

NCT03691610Phase 3

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

Completed

NCT00496054Phase 3

Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)

Completed

NCT00953056Phase 1

A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)

Completed

NCT01003431Phase 3

A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

Withdrawn

NCT00258154Phase 3

V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)

Completed

NCT00092456Phase 3

Consistency Lots Vaccine Study (V260-009)

Completed

NCT00166517Phase 3

V260 Registration Study (V260-013)(COMPLETED)

Completed

NCT00130832Phase 3

Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)